Daily Dose - Nov 19th, 2024
Daily Dose |
View online
November 19, 2024
The top 4 of 2024
A rundown of 2024’s defining pharma moments, from game-changing therapies to billion-dollar deals.
Read More
FDA grants Regenxbio accelerated approval pathway for Duchenne gene therapy trial
A Biologics License Application (BLA) submission is planned for 2026.
Read More
Sanofi invests $42M in Lyon for drug production
Of the investment, $26.4 million will be allocated to transplant antibodies and $15.8 million in diabetes treatments.
Read More
Off Script: A Pharma Manufacturing Podcast
The Off Script podcast offers in-depth interviews and discussions with industry experts about hot-button topics in pharma, and goes behind the scenes of Pharma Manufacturing's print and online coverage.
Listen now